Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517744) titled 'Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia' on April 2.

Study Type: Observational

Primary Sponsor: Ain Shams University

Condition: CKD Anemia CKD Anemia in Stable Dialysis Patients

Recruitment Status: Not recruiting

Date of First Enrollment: June 1, 2024

Target Sample Size: 35

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07517744

Published by HT Digital Content Services with permission from Health Daily Digest....